ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
354 hedge funds and large institutions have $7.12B invested in Intra-Cellular Therapies Inc. in 2024 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 133 increasing their positions, 129 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 375 → 354 (-21)
31% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 62
Holders
354
Holding in Top 10
10
Calls
$27.3M
Puts
$14.7M
Top Buyers
| 1 | +$139M | |
| 2 | +$94.3M | |
| 3 | +$49.8M | |
| 4 |
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Warszawa,
Poland
|
+$30.4M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
+$27.4M |
Top Sellers
| 1 | -$34.8M | |
| 2 | -$32.6M | |
| 3 | -$30.5M | |
| 4 |
Millennium Management
New York
|
-$29.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29M |